Emicizumab

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 889 publications

Acquired haemophilia A associated with prostate cancer managed with recombinant activated factor VII and emicizumab.

Acquired haemophilia A associated with prostate cancer managed with recombinant activated factor VII and emicizumab.

Journal: BMJ case reports

Published: August 17, 2026

Remission-driven discontinuation shapes the observed duration of emicizumab in acquired hemophilia A. Comment on: "Short-term emicizumab in patients with acquired hemophilia A".

Remission-driven discontinuation shapes the observed duration of emicizumab in acquired hemophilia A. Comment on: "Short-term emicizumab in patients with acquired hemophilia A".

Journal: Haematologica

Published: August 13, 2026

Emicizumab and Recombinant FVIIa for Safe Surgical Removal of a Massive Pseudotumor in Severe Hemophilia A with Inhibitor.

Emicizumab and Recombinant FVIIa for Safe Surgical Removal of a Massive Pseudotumor in Severe Hemophilia A with Inhibitor.

Journal: Seminars in thrombosis and hemostasis

Published: August 04, 2026

Advances in treatments for hemophilia A/B with inhibitors: current treatment gaps and promising therapies.

Advances in treatments for hemophilia A/B with inhibitors: current treatment gaps and promising therapies.

Journal: Expert review of hematology

Published: July 08, 2026

Update: Immune Tolerance Induction Practice in Haemophilia.

Update: Immune Tolerance Induction Practice in Haemophilia.

Journal: Hamostaseologie

Published: July 06, 2026

Multimodal management of refractory gastrointestinal bleeding in myeloma-associated acquired von Willebrand syndrome: a role for emicizumab prophylaxis.

Multimodal management of refractory gastrointestinal bleeding in myeloma-associated acquired von Willebrand syndrome: a role for emicizumab prophylaxis.

Journal: Journal of thrombosis and haemostasis : JTH

Published: June 21, 2026

Balancing hemostasis and thrombosis in aging people with hemophilia

Balancing hemostasis and thrombosis in aging people with hemophilia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: June 03, 2026

Physical Activity, Bleeding Incidence and Health-Related Quality of Life, in Patients With Haemophilia A Without Inhibitors, Treated With Emicizumab: A Post-Hoc Descriptive Analysis of the Power Study Data.

Physical Activity, Bleeding Incidence and Health-Related Quality of Life, in Patients With Haemophilia A Without Inhibitors, Treated With Emicizumab: A Post-Hoc Descriptive Analysis of the Power Study Data.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: May 28, 2026

Changes in Hypertrophic Synovium Status in Adult Patients With Severe Hemophilia A Receiving Emicizumab Prophylaxis: The RESOLVE Study.

Changes in Hypertrophic Synovium Status in Adult Patients With Severe Hemophilia A Receiving Emicizumab Prophylaxis: The RESOLVE Study.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: May 22, 2026

Advances in Hemophilia: New Treatments and Complications in Laboratory Testing/Monitoring.

Advances in Hemophilia: New Treatments and Complications in Laboratory Testing/Monitoring.

Journal: Clinics in laboratory medicine

Published: May 15, 2026

Evaluation of the efficacy and safety of reduced-dose emicizumab in infants with severe hemophilia A: a single-center real-world study

Evaluation of the efficacy and safety of reduced-dose emicizumab in infants with severe hemophilia A: a single-center real-world study

Journal: Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics

Published: May 14, 2026

Successful immune tolerance induction using efanesoctocog alfa in severe hemophilia A: A case series.

Successful immune tolerance induction using efanesoctocog alfa in severe hemophilia A: A case series.

Journal: Journal of thrombosis and haemostasis : JTH

Published: May 01, 2026

Showing 1-12 of 889

Last Updated: 09/26/2026